Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) were found to harbor somatic mutations in SF3a1 and other RNA splicing components, however, SF3a1 mutation status did not show statistically significant correlation with overall survival in this malignancy 32. This evidence concerns the gene SF3A1 and CD4+/CD56+ hematodermic neoplasm.